Stem Cells journal awards human cord-blood research
Dr. Cinzia Rota wins annual young investigator award at International Stem Cell Symposium
The journal stem cells has announced Dr. Cinzia Rota as the winner of the annual Stem Cells Young Investigator Award. Co-sponsored by the International Stem Cell Symposium, the $10,000 prize is annually given to a young scientist who is the principal author of a research paper published in Stem Cells and judged to be most important by the Journal editors.
Dr. Rota, from the Mario Negri Institute for Pharmacological Research in Bergamo, Italy, was awarded the prize for her paper entitled 'Life-Sparing Effect of Human Cord Blood-Mesenchymal Stem Cells in Experimental Acute Kidney Injury.'
"The translation of pre-clinical results into therapies will be an important aspect of stem cell research over the next ten years" said Rota. "Students entering this field should know that it is fascinating, with the opportunity to produce results that can potentially be translated in clinical practice, providing hope in areas where traditional medicine does not offer therapeutic opportunities."
Dr. Rota's award winning paper investigated the potential of human cord blood to cure acute kidney injury. The research revealed the potential for of human cord-blood stem cells as a future cell therapy.
"I think that one of the most important things for the public to understand is the different characteristics and regenerative potentials of human embryonic and adult stem cells; that these cells are not interchangeable, and that one or the other may be better for certain clinical applications," said Rota. "Therefore, detailed studies on ESCs, iPS cells, and adult stem cell are all necessary to provide for future cell therapy applications."
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Cell-based fish from the bioreactor - Alternative to fishing –

Holes in T cells - Study reveals previously unknown function of immune cells
Taconic Biosciences and Cellaria Biosciences collaborate to facilitate xenograft use in oncology research

This is how the superbug Pseudomonas aeruginosa reacts to antibiotics - Specific properties might become targets for drugs
Category:Swiss_biochemists
Validation of the dossier for drug approval of Biofrontera's BF-200 ALA successful
All tied up: Tethered protein provides long-sought answer
Naturalpha launches a clinical investigation center for nutrition
Biosignal: Collaboration with international company on agriculture applications - Evaluation for use in crop protection to be conducted over 9 months
Modified_starch
Indivumed to study the integrity of biospecimen sampling procedures for the U.S. National Cancer Institute - Analysis of biopsy sampling procedures a prerequisite for the development of future individualized cancer therapies
